BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 16246052)

  • 21. Functional plasticity in the substrate binding site of beta-secretase.
    Gorfe AA; Caflisch A
    Structure; 2005 Oct; 13(10):1487-98. PubMed ID: 16216580
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic and pharmacological evidence of intraneuronal Abeta accumulation in APP transgenic mice.
    Philipson O; Lannfelt L; Nilsson LN
    FEBS Lett; 2009 Sep; 583(18):3021-6. PubMed ID: 19683527
    [TBL] [Abstract][Full Text] [Related]  

  • 23. BACE inhibitor reduces APP-beta-C-terminal fragment accumulation in axonal swellings of okadaic acid-induced neurodegeneration.
    Yoon SY; Choi JE; Yoon JH; Huh JW; Kim DH
    Neurobiol Dis; 2006 May; 22(2):435-44. PubMed ID: 16480887
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Promising anti-Alzheimer's dimer bis(7)-tacrine reduces beta-amyloid generation by directly inhibiting BACE-1 activity.
    Fu H; Li W; Luo J; Lee NT; Li M; Tsim KW; Pang Y; Youdim MB; Han Y
    Biochem Biophys Res Commun; 2008 Feb; 366(3):631-6. PubMed ID: 18039469
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Amyloid beta secretase gene (BACE) is neither mutated in nor associated with early-onset Alzheimer's disease.
    Cruts M; Dermaut B; Rademakers R; Roks G; Van den Broeck M; Munteanu G; van Duijn CM; Van Broeckhoven C
    Neurosci Lett; 2001 Nov; 313(1-2):105-7. PubMed ID: 11684351
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Progress toward the discovery and development of efficacious BACE inhibitors.
    Durham TB; Shepherd TA
    Curr Opin Drug Discov Devel; 2006 Nov; 9(6):776-91. PubMed ID: 17117686
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vivo beta-secretase 1 inhibition leads to brain Abeta lowering and increased alpha-secretase processing of amyloid precursor protein without effect on neuregulin-1.
    Sankaranarayanan S; Price EA; Wu G; Crouthamel MC; Shi XP; Tugusheva K; Tyler KX; Kahana J; Ellis J; Jin L; Steele T; Stachel S; Coburn C; Simon AJ
    J Pharmacol Exp Ther; 2008 Mar; 324(3):957-69. PubMed ID: 18156464
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulation of secretases by all-trans-retinoic acid.
    Koryakina A; Aeberhard J; Kiefer S; Hamburger M; Küenzi P
    FEBS J; 2009 May; 276(9):2645-55. PubMed ID: 19476501
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of peptides derived from BACE1 catalytic domain on APP processing.
    Yeon SW; Jeon YJ; Hwang EM; Kim TY
    Peptides; 2007 Apr; 28(4):838-44. PubMed ID: 17293005
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of huperzine A on amyloid precursor protein processing and beta-amyloid generation in human embryonic kidney 293 APP Swedish mutant cells.
    Peng Y; Jiang L; Lee DY; Schachter SC; Ma Z; Lemere CA
    J Neurosci Res; 2006 Sep; 84(4):903-11. PubMed ID: 16862548
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Knife jugglers. Painkillers shift Alzheimer's protein slicer.
    Davenport RJ
    Sci Aging Knowledge Environ; 2004 Sep; 2004(39):nf89. PubMed ID: 15456907
    [No Abstract]   [Full Text] [Related]  

  • 32. Apo and inhibitor complex structures of BACE (beta-secretase).
    Patel S; Vuillard L; Cleasby A; Murray CW; Yon J
    J Mol Biol; 2004 Oct; 343(2):407-16. PubMed ID: 15451669
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Treatment of Alzheimer's disease].
    Ishiura S; Hattori C
    Tanpakushitsu Kakusan Koso; 2004 Nov; 49(14):2179-85. PubMed ID: 15559301
    [No Abstract]   [Full Text] [Related]  

  • 34. Amyloid-beta, BACE, and oxidative stress in Alzheimer's disease, a commentary on "The different aggregation state of beta-amyloid 1-42 mediates different effects on oxidative stress, neurodegeneration and BACE-1 expression".
    Lee HG; Perry G; Zhu X; Nunomura A; Smith MA
    Free Radic Biol Med; 2006 Jul; 41(2):188-9. PubMed ID: 16814097
    [No Abstract]   [Full Text] [Related]  

  • 35. Receptor tyrosine kinases positively regulate BACE activity and Amyloid-beta production through enhancing BACE internalization.
    Zou L; Wang Z; Shen L; Bao GB; Wang T; Kang JH; Pei G
    Cell Res; 2007 May; 17(5):389-401. PubMed ID: 17325690
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Retinoic acid normalizes nuclear receptor mediated hypo-expression of proteins involved in beta-amyloid deposits in the cerebral cortex of vitamin A deprived rats.
    Husson M; Enderlin V; Delacourte A; Ghenimi N; Alfos S; Pallet V; Higueret P
    Neurobiol Dis; 2006 Jul; 23(1):1-10. PubMed ID: 16531051
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Amyloidogenic processing of beta-amyloid precursor protein in intracellular compartments.
    Vetrivel KS; Thinakaran G
    Neurology; 2006 Jan; 66(2 Suppl 1):S69-73. PubMed ID: 16432149
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modulation of neutrophil apoptosis by beta-amyloid proteins.
    Park HY; Park JI; Baek DW; Lee SY; Lee MJ; Jin JO; Kim JW; Hong YS; Lee YH; Kwak JY
    Int Immunopharmacol; 2006 Jul; 6(7):1061-9. PubMed ID: 16714209
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Three novel alternatively spliced isoforms of the human beta-site amyloid precursor protein cleaving enzyme (BACE) and their effect on amyloid beta-peptide production.
    Tanahashi H; Tabira T
    Neurosci Lett; 2001 Jul; 307(1):9-12. PubMed ID: 11516562
    [TBL] [Abstract][Full Text] [Related]  

  • 40. P-glycoprotein efflux and other factors limit brain amyloid beta reduction by beta-site amyloid precursor protein-cleaving enzyme 1 inhibitors in mice.
    Meredith JE; Thompson LA; Toyn JH; Marcin L; Barten DM; Marcinkeviciene J; Kopcho L; Kim Y; Lin A; Guss V; Burton C; Iben L; Polson C; Cantone J; Ford M; Drexler D; Fiedler T; Lentz KA; Grace JE; Kolb J; Corsa J; Pierdomenico M; Jones K; Olson RE; Macor JE; Albright CF
    J Pharmacol Exp Ther; 2008 Aug; 326(2):502-13. PubMed ID: 18499745
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.